Harnessing Transcriptomic Signals for Amyotrophic Lateral Sclerosis to Identify Novel Drugs and Enhance Risk Prediction
Oliver Pain, Ashley Jones, Ahmad Al Khleifat, Devika Agarwal, Dzmitry Hramyka, Hajer Karoui, Jędrzej Kubica, David J. Llewellyn, Janice M. Ranson, Zhi Yao, Alfredo Iacoangeli, Ammar Al‐Chalabi
This study uses GWAS and functional genomics to identify ALS risk genes, repurpose drugs, and improve risk prediction using polytranscriptomic scores.
Heliyon · Jul 29, 2024Peer-reviewedGenetic & Genomic Medicine